Viewing Study NCT00267969

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2026-04-05 @ 6:39 AM
Study NCT ID: NCT00267969
Status: COMPLETED
Last Update Posted: 2013-06-17
First Post: 2005-12-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
Sponsor: Centocor Research & Development, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ustekinumab View
None CNTO1275 View
None Plaque type Psoriasis View
None Interleukin-23 View
None IL-23 View
None Psoriasis View
None Interleukin 12 View
None IL-12 View